Concepedia

Publication | Open Access

Phase II study of trastuzumab in combination with S-1 plus cisplatin in HER2-positive gastric cancer (HERBIS-1)

138

Citations

18

References

2014

Year

Abstract

Trastuzumab in combination with SP showed promising antitumour activity and manageable toxic effects in patients with HER2-positive AGC.

References

YearCitations

Page 1